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Abstract Insomnia is a very frequent problem among the
general population, and it has a high socio-economic
impact on health care management. It produces high
costs because of absenteeism and accidents, and it is
considered to be a risk factor for the development of
psychiatric diseases and other medical disorders. How-
ever, only a low proportion of insomniacs ever seek
professional help. The reasons are still unknown, but
most insomniacs probably consider their problem untreat-
able unless they undergo a therapy with hypnotics.
Knowledge about alternative therapy methods beyond
sleep medication is scarce, and specialized psychotherapy
is not always available. Since dysfunctional behavior and
beliefs are considered to be the central perpetuating
factors for primary insomnia, the role of educational
programs in terms of prevention and treating mild forms
of insomnia is discussed. These workshops could be a
part of a step-by-step treatment of insomnia as has been
proposed recently by Espie.
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Insomnia, prevalence and risk factors
Disturbed sleep is a very frequent problem among the
general population. Prevalence varies depending on
which criteria and assessment methods are used [1].
However, symptoms of disturbed sleep are reported by at
least one fifth of the general population [2]. The
prevalence of insomnia symptoms varies between 19%
and 29% among Europeans [3]. Narrowing down the
criteria to the point at which insomnia becomes a clinical
problem reduces the prevalence to 10% [4–6]. The
general criteria for insomnia according to the Interna-
tional Classification of Sleep Disorders are mainly:
Difficulty initiating or maintaining sleep or waking up
too early and signs of daytime impairment related to non-
restorative sleep, such as fatigue, energy reduction or
worries about sleep [7].
There are some risk factors for developing insomnia.
A recent survey showed that nocturnal awakenings
increased with age: 52% of the persons older than 65
reported nocturnal awakenings in contrast to 16% of
adolescents [8]. A further risk factor for having insomnia
is being female and single [8, 9] and living in large cities
[9]. Also, there seems to be a correlation between low
social economic status and insomnia [10], as well as shift
work [11].
Socio-economic relevance of insomnia for the societies
The problem of insomnia beyond its subjective harm is its
socio-economic relevance for society due to the high costs
of sick leave or accidents [12, 13]. Annual costs for
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insomnia have been estimated to be more than 90 billion
dollars [14]. A further problem is the impact insomnia has
on the development of further psychiatric disorders such as
depression [15]. It has been shown that sleep-disturbed
people have a higher risk of developing depression [4].
Recent studies have shown that intervention for insomnia
either pharmacologic [16] or with Cognitive Behavior
Therapy for Insomnia (CBT-I) [17] may reduce the symptoms
of depression. While it is postulated that a depressive mood
is part of the psychopathology of insomnia [18], some new
data suggest a direct effect of sleep loss by emotional
regulation [19]. The role of insomnia in developing
depression is not clearly understood until now, and the role
of disturbed sleep in the context of psychiatric illness
remains a field of research [20, 21]. However, the treatment
of insomnia especially regarding its role as a link to
developing other diseases has an increasing value in health
care management.
Self-treatment methods or medication?
How do sleep-disturbed people treat insomnia? It is
interesting that although there is a high rate of insomnia
among the population, only a few are seeking professional
help [22]. Most people seem to treat their disturbed sleep by
watching TV, drinking alcohol or using non-prescription
medication [23]. The proportion of insomniacs using
prescriptions seems to be rather low and ranges from 2.6 %
[24] to 11% in France [25]. The reason for this low usage of
professional medical help may be a negative attitude towards
pharmacologic therapy among insomnia patients and there-
fore a low acceptance [26]. The negative effects such as
addiction, hangover, dose escalation and side effects for other
diseases still complicate the prescription of hypnotics,
especially in older persons [27–29]. Another reason is the
short duration (four weeks) of the recommended intake of
hypnotics. Despite newer data showing that long-term use
does not lead to dose escalation [30], a study showing an
average duration of use for prescribed medication in
insomnia patients of 4 years did not yield optimal drug
efficacy in most patients [31].
Current approaches in treating insomnia
In summary we have a high prevalence of insomnia
among the general population, which produces high costs
for society. On the other hand, we have a rather low
proportion of people with insomnia that seek medical
help. Since age is a serious risk factor for developing
insomnia and since there will be a higher proportion of
elderly in our industrialized society in the future, the
effective treatment of insomnia is a current challenge for
health care management. What possible options are
available to reduce the prevalence of insomnia among the
general population?
Perpetuating factors of insomnia as target symptoms
for behavior therapy
In order to evaluate possible preventive and therapeutic
options for insomnia, it is worth looking at its perpetuating
factors. It is evident by now that primary insomnia may
exist without any underlying psychiatric or other organic
sleep disorders. In order to explain the perpetuation of
disturbed sleep, experts have found that psychological
factors are responsible. These models are based on
observations of daytime performance in people with
insomnia. Symptoms of sleep deprivation are not entirely
present in insomniacs [32]. Measuring daytime perfor-
mance with psychomotor tests, insomniacs did not display
results that correspond to their subjective perception of
daytime fatigue [33]. This lack of objective fatigue in
insomniacs was explained by hyperarousal [34, 35]. Several
studies have shown that this heightened arousal is evident
in physiological and psychological parameters [36]. Hyper-
arousal is also evident in presleep EEG, which is
responsible for sleep misperception [37]. Enhanced cogni-
tive rumination, which is a typical symptom in insomniacs,
could be explained by hyperarousal. In the course of
psychological research, several models of persistent prima-
ry insomnia have been described [18, 37, 38]. The main
assumption is that insomnia may exist as an interplay of
psychological factors such as irrational and dysfunctional
beliefs [39], erratic sleep-wake behavior, an enhanced mode
of self-observation [38] and a hyperarousal that prevents
sufficient relaxation for the process of falling asleep [37].
The role of irrational beliefs in this context as a
perpetuating factor has been examined in several studies
[39, 40]. In comparison to healthy controls, insomniacs are
much more worried about the consequences of bad sleep,
especially since they believe that insomnia may be the
cause for bodily and physical damage [39]. Also, insomniacs
often believe in dysfunctional sleep-promoting behavior in
the hope that it will ensure sleep [39]. Prolonged bedtimes
are the most prominent errors made by insomniacs. Since
insomnia patients experience a long wake time in bed, they
try to compensate sleep loss with a longer period of rest. In
consequence, bedtime hours longer than 8 or more hours
lead to an impairment of sleep continuity and to prolonged
wake time at night. Patients notice this loss of sleep
continuity and normally react with frustration. Since they
usually tend to avoid everything that might worsen sleep (in
this case stress because of short bedtimes), they stick to their
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habits. Dysfunctional remarks such as “I am a bad sleeper”
reinforce their insomnia.
Cognitive behavior therapy for insomnia
For treating insomnia a variety of therapeutic strategies already
exist. As far as hypnotics is concerned, especially Benzodiaz-
epine receptor agonists seem to be very effective in treating
insomnia [41, 42]. In addition to the pharmacological
treatment that has been elaborated in the past 20 years, a
specialized behavior therapy form has been established, which
is called cognitive behavior therapy for insomnia (CBT-I).
CBT-I has been developed on the basis of the understanding
that primary insomnia is a conditioned disorder [43, 44]. This
form of insomnia is called psychophysiological insomnia. If
disturbed sleep in insomnia is a result of dysfunctional
thinking and behavior, an effective way to improve sleep
would be to change these thoughts and behaviors. It has been
shown that CBT-I reduces irrational thoughts and that these
improvements correlated with subjective and objective im-
provement of sleep [40]. Identifying and changing dysfunc-
tional thoughts, therefore, has an important impact on the
course of insomnia and it is part of the central educative
elements of CBT-I [44]. One important feature of this module
is that it can be performed using different media (e.g. books,
the Internet) and it is not necessary to have direct contact to a
psychotherapist. However, monitoring the effects of altering
dysfunctional beliefs still needs therapeutic aid.
Table 1 shows the most important modules of CBT-I.
The main module is sleep restriction, which was first
introduced by Spielman et al. [45] and is based on the
hypothesis that prolonged bedtime hours are one of the
factors that perpetuate insomnia. Patients are instructed to
keep certain bedtimes that are restricted in duration to 6 h.
Sleep is not allowed anywhere else or at any other time. By
restricting allowed sleep to a short period at night, sleep
pressure is built up, resulting in improved sleep quality.
Bootzin first saw a relationship between insomnia and the
sleep environment as a discriminative stimulus for sleep [46].
Stimulus control therapy is a very effective strategy in
reducing anticipatoric anxiety and improving sleep [47]. It is
recommended by AASM as the standard non-pharmacological
treatment for insomnia [48]. The technique is based on the
idea of conditioned sleeplessness. If insomniacs experience
disturbed sleep in bed again and again, the bedroom
environment may develop into a stimulus that is incompatible
with sleep, hence with an arousal reaction. Insomnia patients
typically report that they may be very tired, but once they
have gone to bed, they become more and more awake. This is
the result of conditioned awakening in surroundings that
should actually be a discriminative stimulus for sleep.
A third technique is relaxation therapy, since cognitive and
physiological hyperarousal is a central aspect in insomnia. A
variety of relaxation techniques are used, for example
progressive muscle relaxation (PMR), autogenic training,
meditation or biofeedback. It is important that the patient feels
comfortable with the special relaxation technique.
Effectiveness of CBT
Non-pharmacological strategies in the treatment of insom-
nia have their own history. Since Bootzin and Spielman
tried to improve sleep quality with behavior therapy
modules, a compelling number of studies have been carried
out to prove the effectiveness of CBT-I. Studies so far show
that CBT-I is more effective than no treatment [49, 50] and
than PMR and Placebo [51]. The advantage of CBT is its
long-term effect beyond the end of therapy [52–54]. This is
a very promising feature of CBT, since the long-term use of
hypnotics remains a matter of debate. The fact that CBT-I
has an enduring positive effect strengthens the hypothesis
that sleep improvement is a result of a learning process.
Once patients have an insight into dysfunctional behavior
and once they are able to alter behavior patterns that are
incompatible with sleep, sleep may improve. Patients are
able to regain control over the process of sleep.
Meanwhile several meta-analyses have shown its effec-
tiveness, even if insomnia is associated with other psychi-
atric disorders or medical illnesses [54–56]. However, the
disadvantage is the need for an elaborated therapist. The
current issue in insomnia therapy management, therefore, is
not whether but how to transport therapy tools to the people
who need them.
Learning how to sleep
At this point the learning mechanism of CBT-I turns out to
be valuable. If the alternation between dysfunctional and
Table 1 Methods of cognitive behavior therapy for insomnia
Method Treatment goal
Sleep restriction Improving sleep continuity by
shortening bedtime hours
Stimulus control Redefining the emotional value
of the sleep environment by
only allowing sleep in bed
Sleep education Alteration of dysfunctional
attitudes and irrational
beliefs regarding sleep
in order to reduce
sleep-related fears
Relaxation therapy Reduction of hyperarousal
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sleep-incompatible behavior is the basic mechanism, it
seems reasonable to offer educational programs. Educa-
tional programs have several advantages. First, they can be
applied with different media (e.g. Internet, books). Second,
they can be developed according to the current standards of
therapy, and third, they reach a wide range of people.
Educational programs could be offered in companies or
factories, for example, for shift workers. Programs could be
adapted for schoolchildren or the needs of older people.
There are some data that already exist about self-help
programs and short interventions, such as workshops.
Zulley et al. offered an educational program supported by
a German health insurance company. The focus of the
seminar lies in lectures on normal sleep and sleep disorders.
Therapy methods, such as bedtime restriction and relaxa-
tion techniques, are taught. Changing dysfunctional beliefs
was also a central aspect of these educational programs.
The class was open to anyone who was interested. No
initial examination was done. However, as was expected,
mostly sleep-disturbed people participated. A follow-up
evaluation was done with 167 participants after 3 months.
The sample consisted of 110 women and 57 men between the
ages of 21–88 years, with a mean of 54 years. Two days of
education had a positive effect on the perpetuating factors of
insomnia: The majority changed their sleep habits. Of the
63.5% of participants with a previous consumption of
hypnotics, 80 % reported a reduction in consumption, with
20 % of them having stopped taking sleep medications. An
improvement of sleep 3 months after the seminar was found in
79.6 %. This outcome shows the beneficial effect of such a
seminar, which may contribute to the prevention of sleep
disorders. The outcome is similar to a recently published trial
in London, where sleep-disturbed volunteers were educated in
workshops. A 1-day workshop was proven to be effective in
the reduction of insomnia symptoms and depression [57].
Options of applying CBT-I
Espie [58] proposed a step-by-step therapy for insomniacs.
Self-administered CBT-I on the entry level could be helpful
in insomnia, as has been shown before [59]. Although the
effects at this therapy level are modest, [60] they might be
useful in an integrated step-by-step therapy algorithm. A
Canadian group showed that improvement could be achieved
in people with insomnia simply by distributing educational
material (6 booklets) and with telephone consulting [61]. As
has been suggested by Espie, a small number of CBT-I
interventions could be done by nurses. For more difficult and
complex cases of insomnia patients, CBT-I could be done by
psychotherapists in a setting with standardized number of
therapy hours. More research is necessary to evaluate the
procedures for referrals in the health care system.
Conclusions and outlook
Insomnia is not always insomnia. It might exist as a symptom
as well as a special sleep disorder or a complicated psychiatric
disorder with comorbid conditions. In any case, insomnia is a
socio-economic risk factor. Elaborated CBT-I therapy pro-
grams may be too difficult to apply broadly, since they need
special initial diagnostic procedures and qualified psycho-
therapists. A step-by-step treatment of insomnia may reduce
its prevalence, especially in mild forms of insomnia.
Educative modules of CBT-I (for example information
about normal sleep and the perpetuating factors of insomnia
including maladaptive sleep behavior) could be offered
broadly in several ways (insomnia lectures in schools or
senior citizens homes, DVD, etc.). In this way the develop-
ment of dysfunctional beliefs about sleep (“I must have at
least 7 h of sleep”) and behavior could be prevented. Primary
insomnia as a sleep disorder should be diagnosed and treated
in ambulatory settings, general practioneers or by specialized
therapists. On this health care level a differentiation between
insomnia and other comorbid psychiatric disorders is impor-
tant. CBT-I can be offered for patients in an ambulatory setting
in six to eight weekly sessions or in a weekend workshop.
These sessions should be offered by psychotherapists. Patients
who are difficult to treat, who have problems to dismiss their
hypnotic medication or show a severe psychiatric comorbid
disorders could be treated in a standardized program for CBT-I
either in a psychiatric clinic [62] or a similar setting.
Further research is necessary to show the effectiveness in
gradually tailoring of CBT-I for different forms of
insomnia.
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